The emergence of meticillin-resistant Staphylococcus aureus among injecting drug users

Journal of Infection

Volumn 58, Issue 5, 2009, Pages 339-345

  Atkinson, S R ^a   Paul, J ^a   Sloan, E ^b   Curtis, S ^c   Miller, R ^d  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Injecting drug use; MRSA; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; DAPTOMYCIN; ERYTHROMYCIN; FUSIDATE SODIUM; GENTAMICIN; LINEZOLID; METICILLIN; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BONE INFECTION; CONTROLLED STUDY; ENDOCARDITIS; HOSPITAL ADMISSION; HUMAN; INFECTION RATE; INFECTIOUS ARTHRITIS; INJECTION SITE INFECTION; INTRAVENOUS DRUG ABUSE; LUNG INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POPULATION STRUCTURE; SEPSIS; SOFT TISSUE INFECTION; STRAIN DIFFERENCE;

ABSCESS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DNA, BACTERIAL; DRUG USERS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RNA, RIBOSOMAL, 16S; SEPSIS; STAPHYLOCOCCAL INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 67349280163     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.03.004     Document Type: Article

References (27)

1. Aldeyab M.A., Monnet D.L., López-Lozano J.M., Hughes C.M., Scott M.G., Kearney M.P., et al. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 62 3 (2008) 593-600
2. Barnard J.B., Barjolin J.C., and Cyster R. Funding and planning drive to support shared care and drug misuse services in 2001. SMMGP Newslett 19 (2001) 1-2
3. Bassetti S., and Battegay M. Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies. Infection 32 3 (2004) 163-169
4. Binswanger IA., Kral AH., Bluthenthal RN., Rybold DJ., and Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 30 3 (2000) 579-581
5. Bochet M., Francois P., Longtin Y., Gaide O., Renzi G., and Harbarth S. Community-acquired methicillin-resistant Staphylococcus aureus infections in two scuba divers returning from the Philippines. J Travel Med 15 5 (2008) 378-381
6. Campbell K.M., Vaughn A.F., Russell K.L., Smith B., Jimenez D.L., Barrozo C.P., et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol. 42 9 (2004) 4050-4053
7. Charlebois ED., Bangsberg DR., Moss NJ., Moore MR., Moss AR., Chambers HF., et al. Population-based community prevalence of meticillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 34 4 (2002) 425-433
8. Curtis S. Clinical features and bacteriology of injecting drug users in Brighton. Thesis for the degree of Doctor of Medicine. University of London (unpublished observations).
9. Enright MC., Day NP., Davies CE., Peacock S.J., and Spratt B.G. Multilocus sequence typing for characterization of meticillin-resistant and meticillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 38 3 (2000) 1008-1015
10. Gammell C., and Elsworth C. 'Flesh-eating' MRSA threatens Britain (2008), The Telegraph, London
11. Harmsen D., Claus H., Witte W., Rothgänger J., Claus H., Turnwald D., et al. Typing of meticillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 41 12 (2003 Dec) 5442-5448
12. Hickman M., Higgins V., Hope V., Bellis M., Tilling K., Walker A., et al. Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. J Epidemiol Community Health 58 9 (2004) 766-771
13. Huang H., Flynn NM., King JH., Monchaud C., Morita M., and Cohen S.H. Comparisons of community-associated meticillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 44 7 (2006) 2423-2427
14. Jukka C., Al-Abri S., Anson J., Corkill J., Curnow J., and Beeching N.J. A cluster of community-acquired bacteraemias in an intravenous drug-using population due to a novel clonal strain of meticillin-resistant Staphylococcus aureus. Clin Microbiol Infect 10 Suppl. 3 (2004) 24
15. Lettington W. Meticillin resistant Staphylococcus aureus (MRSA) in an injecting heroin user: implications for hygiene in police station custody suites. J Clin Forensic Med 9 4 (2002) 175-177
16. McClure J.A., Conly J.M., Lau V., Elsayed S., Louie T., Hutchins W., et al. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of meticillin-susceptible from -resistant staphylococci. J Clin Microbiol 44 3 (2006) 1141-1144
17. Miller R., Esmail H., Peto T., Walker S., Crook D., and Wyllie D. Is MRSA admission bacteraemia community-acquired? A case control study. J Infect 56 3 (2008) 163-170
18. Monk AB., Curtis S., Paul J., and Enright MC. Genetic analysis of Staphylococcus aureus from intravenous drug user lesions. J Med Microbiol 53 Pt 3 (2004) 223-227
19. Qi W., Ender M., O'Brien F., Imhof A., Ruef C., McCallum N., et al. Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Zurich, Switzerland (2003): prevalence of type IV SCCmec and a new SCCmec element associated with isolates from intravenous drug users. J Clin Microbiol 43 10 (2005) 5164-5170
20. Roe S, Man L. Drug misuse declared: findings from the 2005/06 British crime survey (England and Wales). H. Office.
21. Salgado C.D., Farr B.M., and Calfee D.P. Community-acquired meticillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 2 (2003) 131-139
22. Tsigrelis C., Armstrong M.D., Vlahakis N.E., Batsis J.A., and Baddour L.M. Infective endocarditis due to community-associated methicillin-resistant Staphylococcus aureus in injection drug users may be associated with Panton-Valentine leukocidin-negative strains. Scand J Infect Dis 39 4 (2007) 299-302
23. Tuazon C.U. Skin and skin structure infections in the patient at risk: carrier state of Staphylococcus aureus. Am J Med 76 5A (1984) 166-171
24. Tuazon C.U., and Sheagren J.N. Staphylococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med 82 6 (1975) 788-790
25. Vlahov D., Sullivan M., Astemborski J., and Nelson K.E. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep 107 5 (1992) 595-598
26. Young DM., Harris HW., Charlebois ED., Chambers H., Campbell A., Perdreau-Remington F., et al. An epidemic of meticillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 139 9 (2004) 947-951 Discussion, p. 951-953
27. Wassenberg M.W., Hopmans T.E., Troelstra A., Kluytmans J.A., and Bonten M.J. Methicillin-resistant Staphylcoccus aureus of livestock origin in Dutch hospitals: high risk patients need only be investigated if admitted to hospital. Ned Tijdschr Geneeskd 152 49 (2008) 2681-2688